Ваксигрип

Ваксигрип is an inactivated influenza vaccine designed to protect against seasonal flu strains, including A/H1N1 and B viruses. This seasonal vaccine is administered via injection to help reduce the risk of influenza infection. Suitable for adults and children, it is widely used in EU markets.

Ваксигрип is used to provide seasonal influenza immunization against common flu strains. It helps the immune system recognize and fight influenza viruses, reducing the likelihood of infection. The vaccine is updated annually to match circulating virus strains, offering protection during flu season. It is commonly used by individuals seeking seasonal flu prevention.

After vaccination, the body begins building immunity against influenza viruses over a few weeks. Common effects include mild soreness at the injection site or slight fatigue. Some individuals may experience low-grade fever or muscle aches, which typically resolve within a day or two. These are normal responses as the immune system responds to the vaccine.

Store Ваксигрип refrigerated between 2°C and 8°C and protect from light. Do not freeze. Before use, inspect the vial for particles or discoloration. Discard if the solution appears cloudy or contains foreign particles. Keep out of reach of children. Consult a healthcare provider if you have a fever or severe illness before vaccination.

Ваксигрип may interact with immunosuppressive therapies or medications affecting the immune system. Avoid receiving other vaccines in the same arm on the same day. If you are taking blood thinners or have a history of severe allergic reactions to eggs or vaccine components, inform your healthcare provider. No known interactions with alcohol or common medications have been established.